Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the results of resolutions presented at its Extraordinary General Meeting on March 24, 2021 and made them available on the dedicated section of its website.
March 25, 2021
· 3 min read